Literature DB >> 20610733

Acyl chain-dependent effect of lysophosphatidylcholine on endothelial prostacyclin production.

Monika Riederer1, Pauli J Ojala, Andelko Hrzenjak, Wolfgang F Graier, Roland Malli, Michaela Tritscher, Martin Hermansson, Bernhard Watzer, Horst Schweer, Gernot Desoye, Akos Heinemann, Sasa Frank.   

Abstract

Previously we identified palmitoyl-lysophosphatidylcholine (16:0 LPC), linoleoyl-LPC (18:2 LPC), arachidonoyl-LPC (20:4 LPC), and oleoyl-LPC (18:1 LPC) as the most prominent LPC species generated by the action of endothelial lipase (EL) on high-density lipoprotein. In the present study, the impact of those LPC on prostacyclin (PGI(2)) production was examined in vitro in primary human aortic endothelial cells (HAEC) and in vivo in mice. Although 18:2 LPC was inactive, 16:0, 18:1, and 20:4 LPC induced PGI(2) production in HAEC by 1.4-, 3-, and 8.3-fold, respectively. LPC-elicited 6-keto PGF1α formation depended on both cyclooxygenase (COX)-1 and COX-2 and on the activity of cytosolic phospholipase type IVA (cPLA2). The LPC-induced, cPLA2-dependent (14)C-arachidonic acid (AA) release was increased 4.5-fold with 16:0, 2-fold with 18:1, and 2.7-fold with 20:4 LPC, respectively, and related to the ability of LPC to increase cytosolic Ca(2+) concentration. In vivo, LPC increased 6-keto PGF(1α) concentration in mouse plasma with a similar order of potency as found in HAEC. Our results indicate that the tested LPC species are capable of eliciting production of PGI(2), whereby the efficacy and the relative contribution of underlying mechanisms are strongly related to acyl-chain length and degree of saturation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610733      PMCID: PMC2936763          DOI: 10.1194/jlr.M006536

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  60 in total

1.  Role of the blood-brain barrier in the formation of long-chain omega-3 and omega-6 fatty acids from essential fatty acid precursors.

Authors:  S A Moore; E Yoder; A A Spector
Journal:  J Neurochem       Date:  1990-08       Impact factor: 5.372

2.  Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein.

Authors:  S Parthasarathy; U P Steinbrecher; J Barnett; J L Witztum; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

3.  Interaction of lysophosphatidylcholine with aortic endothelial cells.

Authors:  L L Stoll; H J Oskarsson; A A Spector
Journal:  Am J Physiol       Date:  1992-06

4.  The G protein-coupled receptor GPR4 suppresses ERK activation in a ligand-independent manner.

Authors:  Meryem Bektas; Larry S Barak; Puneet S Jolly; Hong Liu; Kevin R Lynch; Emanuela Lacana; Ki-Beom Suhr; Sheldon Milstien; Sarah Spiegel
Journal:  Biochemistry       Date:  2003-10-28       Impact factor: 3.162

5.  Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells.

Authors:  N Kume; M I Cybulsky; M A Gimbrone
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

6.  Lysophosphatidylcholine-induced modulation of Ca(2+)-activated K(+)channels contributes to ROS-dependent proliferation of cultured human endothelial cells.

Authors:  Christoph Rüdiger Wolfram Kuhlmann; Dörte Wiebke Lüdders; Christian Alexander Schaefer; Astrid Kerstin Most; Ulrich Backenköhler; Thomas Neumann; Harald Tillmanns; Ali Erdogan
Journal:  J Mol Cell Cardiol       Date:  2004-05       Impact factor: 5.000

7.  G2A is a proton-sensing G-protein-coupled receptor antagonized by lysophosphatidylcholine.

Authors:  Naoka Murakami; Takehiko Yokomizo; Toshiaki Okuno; Takao Shimizu
Journal:  J Biol Chem       Date:  2004-07-27       Impact factor: 5.157

8.  G protein-coupled receptors GPR4 and TDAG8 are oncogenic and overexpressed in human cancers.

Authors:  Wun Chey Sin; Yaoping Zhang; Wendy Zhong; Sree Adhikarakunnathu; Scott Powers; Tim Hoey; Songzhu An; Jianxin Yang
Journal:  Oncogene       Date:  2004-08-19       Impact factor: 9.867

9.  Substrate specificity of plasma lysolecithin acyltransferase and the molecular species of lecithin formed by the reaction.

Authors:  P V Subbaiah; C H Chen; J D Bagdade; J J Albers
Journal:  J Biol Chem       Date:  1985-05-10       Impact factor: 5.157

10.  COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARdelta activation.

Authors:  Mallika Ghosh; Haibin Wang; Youxi Ai; Elisa Romeo; James P Luyendyk; Jeffrey M Peters; Nigel Mackman; Sudhansu K Dey; Timothy Hla
Journal:  J Exp Med       Date:  2007-08-27       Impact factor: 14.307

View more
  20 in total

1.  Targeted Metabolomics Shows Low Plasma Lysophosphatidylcholine 18:2 Predicts Greater Decline of Gait Speed in Older Adults: The Baltimore Longitudinal Study of Aging.

Authors:  Marta Gonzalez-Freire; Ruin Moaddel; Kai Sun; Elisa Fabbri; Pingbo Zhang; Mohammed Khadeer; Norman Salem; Luigi Ferrucci; Richard D Semba
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-01-01       Impact factor: 6.053

Review 2.  Do not let death do us part: 'find-me' signals in communication between dying cells and the phagocytes.

Authors:  C B Medina; K S Ravichandran
Journal:  Cell Death Differ       Date:  2016-02-19       Impact factor: 15.828

3.  The impact of chronic stress on the rat brain lipidome.

Authors:  T G Oliveira; R B Chan; F V Bravo; A Miranda; R R Silva; B Zhou; F Marques; V Pinto; J J Cerqueira; G Di Paolo; N Sousa
Journal:  Mol Psychiatry       Date:  2015-03-10       Impact factor: 15.992

4.  Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers.

Authors:  Cavin K Ward-Caviness; Tao Xu; Thor Aspelund; Barbara Thorand; Corinna Montrone; Christa Meisinger; Irmtraud Dunger-Kaltenbach; Astrid Zierer; Zhonghao Yu; Inga R Helgadottir; Tamara B Harris; Lenore J Launer; Andrea Ganna; Lars Lind; Gudny Eiriksdottir; Melanie Waldenberger; Cornelia Prehn; Karsten Suhre; Thomas Illig; Jerzy Adamski; Andreas Ruepp; Wolfgang Koenig; Vilmundur Gudnason; Valur Emilsson; Rui Wang-Sattler; Annette Peters
Journal:  Heart       Date:  2017-03-02       Impact factor: 5.994

5.  Prevention of 1-palmitoyl lysophosphatidylcholine-induced inflammation by polyunsaturated acyl lysophosphatidylcholine.

Authors:  Nguyen Dang Hung; Dai-Eun Sok; Mee Ree Kim
Journal:  Inflamm Res       Date:  2012-01-18       Impact factor: 4.575

6.  Lysophosphatidylcholine Drives Neuroblast Cell Fate.

Authors:  Luciana Paoletti; Pablo Domizi; Hebe Marcucci; Aneley Montaner; Dario Krapf; Gabriela Salvador; Claudia Banchio
Journal:  Mol Neurobiol       Date:  2015-11-14       Impact factor: 5.590

7.  A dual substrate-accessing mechanism of a major facilitator superfamily protein facilitates lysophospholipid flipping across the cell membrane.

Authors:  Yibin Lin; R N V Krishna Deepak; Jonathan Zixiang Zheng; Hao Fan; Lei Zheng
Journal:  J Biol Chem       Date:  2018-10-29       Impact factor: 5.157

8.  Docosahexaenoic acid-induced unfolded protein response, cell cycle arrest, and apoptosis in vascular smooth muscle cells are triggered by Ca²⁺-dependent induction of oxidative stress.

Authors:  Slaven Crnkovic; Monika Riederer; Margarete Lechleitner; Seth Hallström; Roland Malli; Wolfgang F Graier; Jörg Lindenmann; Helmut Popper; Horst Olschewski; Andrea Olschewski; Saša Frank
Journal:  Free Radic Biol Med       Date:  2012-03-03       Impact factor: 7.376

9.  Acyl chain-dependent effect of lysophosphatidylcholine on endothelium-dependent vasorelaxation.

Authors:  Shailaja P Rao; Monika Riederer; Margarete Lechleitner; Martin Hermansson; Gernot Desoye; Seth Hallström; Wolfgang F Graier; Saša Frank
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

10.  Lysophosphatidylcholine enhances NGF-induced MAPK and Akt signals through the extracellular domain of TrkA in PC12 cells.

Authors:  Asako Itakura; Yuri Matsuki; Masato Tanaka; Manabu Arioka
Journal:  FEBS Open Bio       Date:  2013-05-30       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.